Logo

HUN

Huntsman Corporation

HUN

Huntsman Corporation NYSE
$10.42 3.37% (+0.34)

Market Cap $1.81 B
52w High $20.94
52w Low $7.30
Dividend Yield 1.00%
P/E -5.73
Volume 3.99M
Outstanding Shares 173.75M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $1.46B $198M $-25M -1.712% $-0.14 $86M
Q2-2025 $1.458B $302M $-158M -10.837% $-0.92 $-46M
Q1-2025 $1.41B $159M $-5M -0.355% $-0.03 $115M
Q4-2024 $1.452B $251M $-141M -9.711% $-0.82 $13M
Q3-2024 $1.54B $192M $-33M -2.143% $-0.12 $125M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $468M $7.082B $4.081B $2.766B
Q2-2025 $399M $7.147B $4.086B $2.828B
Q1-2025 $334M $7.232B $4.061B $2.951B
Q4-2024 $340M $7.114B $3.951B $2.959B
Q3-2024 $330M $7.334B $3.989B $3.112B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-25M $196M $-42M $-83M $69M $153M
Q2-2025 $-159M $91M $-38M $9M $65M $54M
Q1-2025 $12M $-74M $6M $60M $-6M $-110M
Q4-2024 $-110M $153M $-39M $-95M $10M $102M
Q3-2024 $-21M $129M $-7M $-129M $-5M $88M

Revenue by Products

Product Q4-2024Q1-2025Q2-2025Q3-2025
Diversified
Diversified
$1.21Bn $1.17Bn $1.20Bn $1.20Bn
Product and Service Other
Product and Service Other
$10.00M $10.00M $10.00M $10.00M
Specialty
Specialty
$240.00M $240.00M $250.00M $250.00M

Five-Year Company Overview

Income Statement

Income Statement Revenue has drifted down from its peak a few years ago, and profitability has come under clear pressure. Margins that were once healthy are now thin, with operating results slipping from solidly profitable to roughly breakeven and then slightly negative most recently. Net income has swung from strong profits to a modest loss, showing how sensitive Huntsman still is to economic cycles, pricing, and demand in its end markets. Overall, the income statement reflects a business in a cyclical down phase, working through weaker conditions after a very strong 2021–2022 period.


Balance Sheet

Balance Sheet The balance sheet is still anchored by a sizeable equity base, but the cushion has narrowed. Total assets have edged down from their highs, while equity has gradually stepped lower, reflecting recent weak earnings and possible shareholder returns. Debt has ticked up from earlier lows, and cash on hand is now noticeably below prior peak levels, leaving less liquidity than before. The company still appears more equity- than debt‑funded, but with less room for error than a few years ago, making future earnings recovery important for balance sheet strength.


Cash Flow

Cash Flow Cash generation from the core business has weakened compared with the strong years in the early 2020s but remains positive. Operating cash flow is much lower than during the peak period, yet still covers ongoing investment in the business. Capital spending has stayed relatively steady and manageable, which has helped keep free cash flow just positive after a brief dip into slightly negative territory. This paints a picture of a company that is still generating cash, but with a slimmer buffer and greater dependence on a rebound in profitability to rebuild flexibility.


Competitive Edge

Competitive Edge Huntsman has deliberately repositioned itself away from bulk, low-margin chemicals toward more specialized, higher-value products. Its strength lies in key chemistries such as MDI-based polyurethanes, amines, and epoxy resins, which are embedded in customers’ processes and hard to replace quickly. The company benefits from a broad global footprint and close technical collaboration with customers, which deepens relationships and raises switching costs. These factors create a meaningful, though not absolute, competitive moat that can help support pricing and margins when market conditions normalize, even though the business remains exposed to industrial and construction cycles.


Innovation and R&D

Innovation and R&D Innovation is a central part of Huntsman’s strategy. The company invests steadily in research and development to push into more differentiated, technology-driven niches. It is developing advanced polyurethane systems for electric vehicle batteries, high-purity amines for semiconductor manufacturing, and carbon‑nanotube‑based materials for next‑generation composites, alongside well-known brands like ARALDITE adhesives and spray-foam insulation solutions. Huntsman is also focusing on more sustainable and bio-based products, which can align with tightening regulations and customer demand. This ongoing R&D effort supports a pipeline of higher-value offerings that, if successfully commercialized, can gradually improve the mix and resilience of the business over time.


Summary

Huntsman today looks like a specialty chemicals company in the middle of a cyclical downturn but with a more differentiated portfolio than in the past. Earnings and margins have compressed significantly from earlier highs, and the balance sheet, while still anchored by meaningful equity, now has less liquidity and more reliance on future profit recovery. Cash flows remain positive but thinner, underscoring the importance of better operating conditions. On the strategic side, the shift toward specialty chemistries, strong positions in key product areas, and a sustained push in innovation for sectors like insulation, semiconductors, electric vehicles, and advanced materials create real opportunities. The main tension for observers is whether and how quickly cyclical demand and pricing will recover to let these strategic strengths show through in stronger and more stable financial results.